Department of Physiology

  • No. 250 Wu-Xing Street,

    11031 Taipei

Organization profile

Organisation profile

Department of Physiology, School of Medicine was founded since 1960 when Taipei Medical University (TMU) was first established. The Department was chaired by Prof. Tsong-Huan Kuo in 1960, Prof. Jing-Yi Wu in 1964, Prof. Cheng Chang in 1967, Prof. Hong-Rong Liu in 1970 and 1983, Prof. Chung-Jen Huang in 1980, Prof. Li-Hsueh Tsai in 1990, Prof. Wen-Sen Lee in 1998, and Prof. Yi-Hsuan Lee in 2005. From 2010, Prof. Jia-Yi Wang is now served as the department chairman. In 1999, the Biology and Physics sections, which was belonged to the Department of General Sciences, were merged to the Physiology. Since then, the Physiology Department carried the mission of teaching General Biology, General Physics, and Medical Physiology at Taipei Medical University.

Fingerprint Dive into the research topics where Department of Physiology is active. These topic labels come from the works of this organisation's members. Together they form a unique fingerprint.

Apoptosis Medicine & Life Sciences
Cells Chemical Compounds
Endothelial Cells Medicine & Life Sciences
Endothelial cells Chemical Compounds
Heme Oxygenase-1 Medicine & Life Sciences
terbinafine Medicine & Life Sciences
Proteins Medicine & Life Sciences
Aryl Hydrocarbon Receptors Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2010 2020

發展一新型藥物作為改善肥胖及肥胖引發糖尿病導致腎病變症候群之轉譯醫學研究(1/3)

Lin, H.

8/1/197/1/20

Project: A - Government Institutionb - Ministry of Science and Technology

辛伐他汀抗腎細胞癌的作用,經由抑制代謝重編程從mTOR、PPAR到RhoA(1/3)

Juan, S.

8/1/197/1/20

Project: A - Government Institutionb - Ministry of Science and Technology

英明格引發呼吸道過度敏感:肺C纖維的角色(2/3)

Lin, Y.

8/1/197/1/20

Project: A - Government Institutionb - Ministry of Science and Technology

Research Output 1989 2020

Aza-PBHA, a potent histone deacetylase inhibitor, inhibits human gastric-cancer cell migration via PKCα-mediated AHR-HDAC interactions

Tsai, C. H., Li, C. H., Liao, P. L., Chang, Y. W., Cheng, Y. W. & Kang, J. J., Feb 2020, In : Biochimica et Biophysica Acta - Molecular Cell Research. 1867, 2, 118564.

Research output: Contribution to journalArticle

Aryl Hydrocarbon Receptors
Histone Deacetylase Inhibitors
Histone Deacetylases
Stomach Neoplasms
Cell Movement

Melatonin activates cell death programs for the suppression of uterine leiomyoma cell proliferation

Lin, P. H., Tung, Y. T., Chen, H. Y., Chiang, Y. F., Hong, H. C., Huang, K. C., Hsu, S. P., Huang, T. C. & Hsia, S. M., Jan 1 2020, In : Journal of Pineal Research. 68, 1, e12620.

Research output: Contribution to journalArticle

Leiomyoma
Melatonin
Cell Death
Cell Proliferation
Myometrium

Angiotensin-converting enzyme inhibitors or angiotensin receptor blocker monotherapy retard deterioration of renal function in Taiwanese chronic kidney disease population

Zheng, C. M., Wang, J. Y., Chen, T. T., Wu, Y. C., Wu, Y. L., Lin, H. T., Chiu, S. P., Chang, T. J., Zheng, J. Q., Chu, N. F., Lin, Y. M., Su, S. L., Lu, K. C., Chen, J. S., Sung, F. C., Lee, C. T., Yang, Y., Hwang, S. J., Wang, M. C., Hsu, Y. H. & 4 others, Chiou, H. Y., Kao, S., Wu, M. Y. & Lin, Y. F., Dec 1 2019, In : Scientific Reports. 9, 1, 2694.

Research output: Contribution to journalArticle

Open Access
Angiotensin Receptor Antagonists
Chronic Renal Insufficiency
Angiotensin-Converting Enzyme Inhibitors
Angiotensins
Kidney